je.st
news
Biogen is crashing after cutting the outlook for its blockbuster drug
2015-07-24 22:19:24| Biotech - Topix.net
Biogen shares fell more than 19% on Friday after quarterly earnings results that beat on profits but missed on revenues. Also, the biotech giant lowered its forecast for full-year earnings and sales because it doesn't expect Tecfidera, its key multiple sclerosis drug, to grow as expected.
Tags: its
drug
cutting
outlook
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||